Amicus Therapeutics Stock Price

-0.26 (-1.14%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Amicus Therapeutics Inc FOLD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.26 -1.14% 22.63 00:00:01
Open Price Low Price High Price Close Price Previous Close
23.50 22.52 23.50 22.63 22.89
Bid Price Ask Price Spread News
20.51 24.50 3.99 - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
16,044 2,746,827 $ 22.83 $ 62,704,751 2,101,454 6.25 - 23.57
Last Trade Time Type Quantity Stock Price Currency
16:12:28 priorref 895 $ 22.63 USD

Amicus Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.90B 260.59M 259.01M $ 182.24M $ - -1.51 -19.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Amicus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FOLD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week22.5923.5722.0322.852,062,1700.040.18%
1 Month17.8523.5717.8521.812,098,7394.7826.78%
3 Months13.3723.5712.77517.592,014,1989.2669.26%
6 Months12.4823.5710.4815.682,098,23810.1581.33%
1 Year10.5123.576.2512.452,496,62212.12115.32%
3 Years13.8423.576.2512.492,534,6228.7963.51%
5 Years10.7523.574.4111.002,575,72211.88110.51%

Amicus Therapeutics Description

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Currently, the company is focused on treating Fabry Disease with its treatment Galafold and developing additional therapies for Fabry patients. Amicus has also received breakthrough therapy designation that allows it to deploy a therapy for Pompe Disease in late-stage patients.

Your Recent History
Amicus The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.